Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 3
2005 3
2006 1
2007 2
2008 2
2009 1
2011 4
2012 1
2013 2
2014 1
2015 2
2016 4
2017 5
2018 5
2019 2
2020 2
2021 6
2022 3
2023 3
2024 7
2025 4
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Incidence of hepatitis C virus infection in the prison setting: The SToP-C study.
Hajarizadeh B, Carson JM, Byrne M, Grebely J, Cunningham E, Amin J, Vickerman P, Martin NK, Treloar C, Martinello M, Lloyd AR, Dore GJ; SToP-C study group. Hajarizadeh B, et al. J Viral Hepat. 2024 Jan;31(1):21-34. doi: 10.1111/jvh.13895. Epub 2023 Nov 7. J Viral Hepat. 2024. PMID: 37936544 Free PMC article.
People in prison are at high risk of HCV given high injecting drug use prevalence. This study evaluated HCV incidence and associated injecting drug use characteristics in prison. The SToP-C study enrolled people incarcerated in four Australian prisons. Partic …
People in prison are at high risk of HCV given high injecting drug use prevalence. This study evaluated HCV incidence and associated …
[Metabolic morbidity in the prison population of Catalonia, Spain].
Marco Mouriño A, Rivera-Esteban J, Augustin S, Turu Santigosa E, Pericàs JM; FatPrison Study Group. Marco Mouriño A, et al. Aten Primaria. 2023 Jun;55(6):102620. doi: 10.1016/j.aprim.2023.102620. Epub 2023 Apr 10. Aten Primaria. 2023. PMID: 37043974 Free PMC article. Spanish.
OBJECTIVE: To investigate the prevalence of metabolic morbidity (MM) amongst prison inmates. DESIGN: Multicentric, cross-sectional observational study. SETTING: All (nine) prisons in Catalonia. ...CONCLUSIONS: In spite of being an overall young population, prison …
OBJECTIVE: To investigate the prevalence of metabolic morbidity (MM) amongst prison inmates. DESIGN: Multicentric, cross-sectional ob …
Prevalence of blood-borne virus infections and uptake of hepatitis C testing and treatment in Australian prisons: the AusHep study.
Bah R, Sheehan Y, Li X, Dore GJ, Grebely J, Lloyd AR, Hajarizadeh B; AusHep study group. Bah R, et al. Lancet Reg Health West Pac. 2024 Nov 21;53:101240. doi: 10.1016/j.lanwpc.2024.101240. eCollection 2024 Dec. Lancet Reg Health West Pac. 2024. PMID: 39633715 Free PMC article.
This national bio-behavioural survey evaluated blood-borne virus prevalence and HCV testing-and-treatment uptake amongst people in Australian prisons. METHODS: Randomly-selected participants from 23 representative prisons nationally were offered point-of-care testin …
This national bio-behavioural survey evaluated blood-borne virus prevalence and HCV testing-and-treatment uptake amongst people in Australia …
Challenges and facilitators in repeated bio-behavioural surveys for blood-borne virus infections in Australian prisons.
Bah R, Sheehan Y, Li X, Price N, Butler T, Dore GJ, Grebely J, Lloyd AR, Hajarizadeh B; AusHep study group. Bah R, et al. Int J Drug Policy. 2025 Oct;144(Pt 1):104401. doi: 10.1016/j.drugpo.2024.104401. Epub 2024 Apr 25. Int J Drug Policy. 2025. PMID: 38670855 Free article.
Regular triennial surveillance has been in place in Australian prisons for almost two decades, but has been focused to date only on new prison entrants. ...This paper aims to identify the challenges and facilitators in conducting bio-behavioural surveys for BBV infe …
Regular triennial surveillance has been in place in Australian prisons for almost two decades, but has been focused to date only on n …
Hepatitis C Virus Reinfection Following Direct-Acting Antiviral Treatment in the Prison Setting: The SToP-C Study.
Carson JM, Dore GJ, Lloyd AR, Grebely J, Byrne M, Cunningham E, Amin J, Vickerman P, Martin NK, Treloar C, Martinello M, Matthews GV, Hajarizadeh B; Surveillance and Treatment of Prisoners With Hepatitis C (SToP-C) Study Group. Carson JM, et al. Clin Infect Dis. 2022 Nov 14;75(10):1809-1819. doi: 10.1093/cid/ciac246. Clin Infect Dis. 2022. PMID: 35362522
METHODS: The Surveillance and Treatment of Prisoners With Hepatitis C (SToP-C) study enrolled people incarcerated in 4 prisons between 2014 and 2019. ...High-coverage OAT and NSPs should be considered within prisons. CLINICAL TRIALS REGISTRATION: NCT02064049. …
METHODS: The Surveillance and Treatment of Prisoners With Hepatitis C (SToP-C) study enrolled people incarcerated in 4 prisons …
Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study.
Hajarizadeh B, Grebely J, Byrne M, Marks P, Amin J, McManus H, Butler T, Cunningham EB, Vickerman P, Martin NK, McHutchison JG, Brainard DM, Treloar C, Chambers GM, Grant L, Mcgrath C, Lloyd AR, Dore GJ; SToP-C study group. Hajarizadeh B, et al. Lancet Gastroenterol Hepatol. 2021 Jul;6(7):533-546. doi: 10.1016/S2468-1253(21)00077-7. Epub 2021 May 7. Lancet Gastroenterol Hepatol. 2021. PMID: 33965006
BACKGROUND: Limited empirical evidence exists for the effectiveness of hepatitis C virus (HCV) treatment-as-prevention. The Surveillance and Treatment of Prisoners with hepatitis C (SToP-C) study aimed to assess the effect of HCV treatment-as-prevention in the prison …
BACKGROUND: Limited empirical evidence exists for the effectiveness of hepatitis C virus (HCV) treatment-as-prevention. The Surveillance and …
Prevalence and characteristics of prisoners requiring end-of-life care: A prospective national survey.
Pazart L, Godard-Marceau A, Chassagne A, Vivot-Pugin A, Cretin E, Amzallag E, Aubry R; PARME Study Group. Pazart L, et al. Palliat Med. 2018 Jan;32(1):6-16. doi: 10.1177/0269216317721816. Epub 2017 Aug 8. Palliat Med. 2018. PMID: 28786339 Free PMC article.
AIM: To assess the number and characteristics of prisoners requiring palliative care in French prisons. DESIGN: A prospective, national survey collecting data over a 3-month period. ...CONCLUSION: The proportion of prisoners requiring palliative care is highe …
AIM: To assess the number and characteristics of prisoners requiring palliative care in French prisons. DESIGN: A prospective, …
Analysis of a Large Severe Acute Respiratory Syndrome Coronavirus 2 (Alpha) Outbreak in a Catalan Prison Using Conventional and Genomic Epidemiology.
Bordoy AE, Vallès X, Fernández-Náger J, Sánchez-Roig M, Fernández-Recio J, Saludes V, Noguera-Julian M, Blanco I, Martró E; Quatre Camins COVID-19 Study Group. Bordoy AE, et al. J Infect Dis. 2024 Aug 16;230(2):374-381. doi: 10.1093/infdis/jiae161. J Infect Dis. 2024. PMID: 38570699
Enforcing strict protocols that prevent transmission of airborne infections in prisons is challenging. We examine a large severe acute respiratory syndrome coronavirus 2 outbreak in a Catalan penitentiary center in February-April 2021, prior to vaccination deployment. ...
Enforcing strict protocols that prevent transmission of airborne infections in prisons is challenging. We examine a large severe acut …
Hepatitis C and B prevalence in Spanish prisons.
Saiz de la Hoya P, Marco A, García-Guerrero J, Rivera A; Prevalhep study group. Saiz de la Hoya P, et al. Eur J Clin Microbiol Infect Dis. 2011 Jul;30(7):857-62. doi: 10.1007/s10096-011-1166-5. Epub 2011 Jan 28. Eur J Clin Microbiol Infect Dis. 2011. PMID: 21274586
Purpose The Prevalhep study seeks to determine the prevalence of factors associated with the hepatitis C (HCV) and B (HBV) virus in Spanish prisoners. Methods This was an observational, cross-sectional study which randomly selected 18 Spanish prisons to participate, …
Purpose The Prevalhep study seeks to determine the prevalence of factors associated with the hepatitis C (HCV) and B (HBV) virus in Spanish …
HIV-1 diversity among inmates of Italian prisons.
Longo B, Novati S, Montieri S, Pontali E, Taglia F, Leo G, Babudieri S, Starnini G, Monarca R, Suligoi B, Rezza G, Ciccozzi M; Italian Study Group on HIV in Prison. Longo B, et al. J Med Virol. 2008 Oct;80(10):1689-94. doi: 10.1002/jmv.21275. J Med Virol. 2008. PMID: 18712824
In Italy, the prevalence of non-B HIV-1 subtypes ranges reportedly from 5.4% to 12.6%, yet there are no data on their circulation in prisons, where the prevalence of HIV infection is high. A retrospective study was conducted to evaluate the circulation of non-B subtypes an …
In Italy, the prevalence of non-B HIV-1 subtypes ranges reportedly from 5.4% to 12.6%, yet there are no data on their circulation in pris …
59 results